uniQure NV (QURE)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
+57.45% vs
Rating Accuracy
100.0% (2 of 2*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+148.87%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+148.87%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+148.87%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+95.12%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Matthew C. Kapusta
Employees
248
Industry
Cardiovascular System Biopharmaceuticals
Sector
Healthcare
Headquarters
Amsterdam
Exchange
NASDAQ
Website
http://www.uniqure.comSummary Stats
Market Cap
1.22B
Revenue
61.4M
Net Income
-125M
EPS
-$2.66
Price-to-Earnings
-9.79
Price-to-Book
2.89
Debt-to-Equity
0.52
News
Analyst Ratings
Price targets projected by 18 analysts
High
$92.00
Average
$70.17
Low
$46.00
Ratings calculated by 20 analysts
Buy
17
Hold
3
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2022
Above by $0.14
-$1.02 +12.1%
-1.16
-0.79
Down 29%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--